These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23274863)

  • 41. Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study.
    Kaltenbach B; Franke J; Bertog SC; Steinberg DH; Hofmann I; Sievert H
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):335-9. PubMed ID: 22807098
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Renal denervation and hypertension.
    Schlaich MP; Krum H; Sobotka PA; Esler MD
    Am J Hypertens; 2011 Jun; 24(6):635-42. PubMed ID: 21394087
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Iatrogenic renal artery stenosis after renal sympathetic denervation.
    Bacaksiz A; Uyarel H; Jafarov P; Kucukbuzcu S
    Int J Cardiol; 2014 Apr; 172(3):e389-90. PubMed ID: 24461484
    [No Abstract]   [Full Text] [Related]  

  • 44. Renal sympathetic denervation for the treatment of systemic hypertension.
    Burke GM; Sica DA; Frishman WH
    Cardiol Rev; 2012; 20(6):274-8. PubMed ID: 22717655
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effectiveness of renal denervation to lower blood pressure questioned. Doctors struggle to explain why the procedure lowers high blood pressure more effectively in some patients than in others.
    Duke Med Health News; 2013 Sep; 19(9):4-5. PubMed ID: 24611189
    [No Abstract]   [Full Text] [Related]  

  • 46. [Catheter-based treatment of drug-resistant hypertension].
    De Benedetti E
    Rev Med Suisse; 2011 Nov; 7(317):2242-4. PubMed ID: 22400353
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Management of arterial hypertension: from no treatment to renal denervation.
    Stefanadis CI
    Hellenic J Cardiol; 2015; 56(3):277-8. PubMed ID: 26021256
    [No Abstract]   [Full Text] [Related]  

  • 48. Hypothesis: Catheter-based renal sympathetic denervation should be the initial therapy for essential hypertension.
    Lakhanpal JR; Domanski MJ
    Med Hypotheses; 2012 Apr; 78(4):482-4. PubMed ID: 22289343
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Renal denervation therapy for hypertension.
    Thukkani AK; Bhatt DL
    Circulation; 2013 Nov; 128(20):2251-4. PubMed ID: 24218440
    [No Abstract]   [Full Text] [Related]  

  • 50. Catheter-based renal denervation: Back on track?
    Lauder L; Ewen S; Böhm M; Mahfoud F
    Eur Heart J; 2018 Dec; 39(46):4058-4059. PubMed ID: 30535015
    [No Abstract]   [Full Text] [Related]  

  • 51. Renal sympathetic-nerve ablation for uncontrolled hypertension.
    Schlaich MP; Sobotka PA; Krum H; Lambert E; Esler MD
    N Engl J Med; 2009 Aug; 361(9):932-4. PubMed ID: 19710497
    [No Abstract]   [Full Text] [Related]  

  • 52. Catheter-based renal denervation: the next chapter begins.
    Mahfoud F; Schlaich M; Böhm M; Esler M; Lüscher TF
    Eur Heart J; 2018 Dec; 39(47):4144-4149. PubMed ID: 30239686
    [No Abstract]   [Full Text] [Related]  

  • 53. Pushing the boundaries of renal denervation for resistant hypertension.
    Bhatt DL
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):340-1. PubMed ID: 23423926
    [No Abstract]   [Full Text] [Related]  

  • 54. Effects of renal denervation on insulin resistance.
    Hering D; Esler MD; Schlaich MP
    Expert Rev Cardiovasc Ther; 2012 Nov; 10(11):1381-6. PubMed ID: 23244359
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of renal sympathetic denervation in a refractory arterial hypertension patient.
    Martínez-Esteban MD; Aranda-Lara P; Muñoz J; Toledo-Rojas R; Sola-Moyano E; Torres-Rueda Á; Hernández-Marrero D
    Nefrologia; 2012; 32(5):670-3. PubMed ID: 23013955
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Safety and short-term efficacy of renal sympathetic denervation in the treatment of resistant hypertension].
    Jiang XJ; Liang T; Dong H; Peng M; Ma WJ; Guan T; Zhang HM; Bian J; Xu B; Gao RL
    Zhonghua Yi Xue Za Zhi; 2012 Dec; 92(46):3265-8. PubMed ID: 23328511
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transcatheter renal artery sympathetic denervation for resistant hypertension: an old paradigm revisited.
    Tam GM; Yan BP; Shetty SV; Lam YY
    Int J Cardiol; 2013 Apr; 164(3):277-81. PubMed ID: 22336259
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Endovascular radiofrequency denervation of renal arteries as an innovation method of treatment of refractory arterial hypertension. First experience in Russia].
    Danilov NM; Matchin IuG; Chazova IE
    Angiol Sosud Khir; 2012; 18(1):51-4. PubMed ID: 22836328
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Denervation (ablation) of nerve terminalis in renal arteries: early results of interventional treatment of arterial hypertension in Poland.
    Bartuś K; Sadowski J; Kapelak B; Zajdel W; Godlewski J; Bartuś S; Bochenek M; Bartuś M; Żmudka K; Sobotka PA
    Kardiol Pol; 2013; 71(2):152-8. PubMed ID: 23575708
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Research needs in the area of device-related treatments for hypertension.
    Jordan J; Mann JF; Luft FC
    Kidney Int; 2013 Aug; 84(2):250-5. PubMed ID: 23447067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.